Zomedica Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $6,997 | $6,131 | $6,262 | $7,337 |
Gross Profit | 5,060 | 2,385 | 4,117 | 5,073 |
EBITDA | -4,696 | -22,097 | -7,395 | |
EBIT | -6,724 | -24,074 | -9,326 | |
Net Income | -6,697 | -23,931 | -9,160 | -22,406 |
Net Change In Cash | 6,997 | 6,131 | 6,262 | 7,337 |
Free Cash Flow | -5,883 | -7,858 | -9,953 | 3,763 |
Cash | 9,747 | 7,939 | 10,939 | 12,952 |
Basic Shares | 979,949 | 979,949 | 979,949 | 979,949 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $25,186 | $18,930 | $4,133 | $14 |
Gross Profit | 17,318 | 13,652 | 3,054 | -530 |
EBITDA | -29,387 | -15,338 | -19,570 | -16,381 |
EBIT | -35,685 | -19,380 | -20,710 | -16,911 |
Net Income | -34,529 | -17,015 | -18,383 | -16,921 |
Net Change In Cash | 25,186 | 18,930 | 4,133 | 14 |
Cost of Revenue | -167,542 | 132,960 | 61,481 | |
Free Cash Flow | -20,621 | -12,696 | -14,801 | -16,256 |
Cash | 12,952 | 27,399 | 194,952 | 61,991 |
Basic Shares | 979,949 | 979,924 | 956,533 | 364,444 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.006 |
2024-06-30 | -$0.02 |
2024-03-31 | -$0.01 |
2023-12-31 | -$0.01 |
